nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0609	0.0974	CbGpPWpGaD
Ergonovine—HTR1E—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0591	0.0946	CbGpPWpGaD
Ergonovine—HTR1E—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0497	0.0795	CbGpPWpGaD
Ergonovine—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0468	0.125	CcSEcCtD
Ergonovine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0308	0.0822	CcSEcCtD
Ergonovine—HTR2C—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0297	0.0476	CbGpPWpGaD
Ergonovine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0276	0.0736	CcSEcCtD
Ergonovine—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0253	0.0405	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0252	0.0403	CbGpPWpGaD
Ergonovine—HTR2C—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.025	0.04	CbGpPWpGaD
Ergonovine—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0213	0.034	CbGpPWpGaD
Ergonovine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0191	0.051	CcSEcCtD
Ergonovine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.019	0.0507	CcSEcCtD
Ergonovine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0496	CcSEcCtD
Ergonovine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0493	CcSEcCtD
Ergonovine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0472	CcSEcCtD
Ergonovine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0433	CcSEcCtD
Ergonovine—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0155	0.0248	CbGpPWpGaD
Ergonovine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0388	CcSEcCtD
Ergonovine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0363	CcSEcCtD
Ergonovine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0357	CcSEcCtD
Ergonovine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0344	CcSEcCtD
Ergonovine—Shock—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0324	CcSEcCtD
Ergonovine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.012	0.0319	CcSEcCtD
Ergonovine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0308	CcSEcCtD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0114	0.0183	CbGpPWpGaD
Ergonovine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.011	0.0294	CcSEcCtD
Ergonovine—HTR2C—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0103	0.0164	CbGpPWpGaD
Ergonovine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0101	0.027	CcSEcCtD
Ergonovine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00977	0.0261	CcSEcCtD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00977	0.0156	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00918	0.0147	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00873	0.014	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—RGS14—nephrolithiasis	0.00861	0.0138	CbGpPWpGaD
Ergonovine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00846	0.0226	CcSEcCtD
Ergonovine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00818	0.0218	CcSEcCtD
Ergonovine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00786	0.021	CcSEcCtD
Ergonovine—HTR1E—Signaling by GPCR—RGS14—nephrolithiasis	0.00782	0.0125	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00781	0.0125	CbGpPWpGaD
Ergonovine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00775	0.0207	CcSEcCtD
Ergonovine—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00757	0.0121	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CHRM3—nephrolithiasis	0.00744	0.0119	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00742	0.0119	CbGpPWpGaD
Ergonovine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00734	0.0196	CcSEcCtD
Ergonovine—HTR1E—GPCR ligand binding—PTH—nephrolithiasis	0.00681	0.0109	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00664	0.0106	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00631	0.0101	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—DGKH—nephrolithiasis	0.00582	0.00931	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00574	0.00918	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00565	0.00903	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ADCY10—nephrolithiasis	0.00543	0.00869	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—DGKH—nephrolithiasis	0.00528	0.00845	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00492	0.00787	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00488	0.00781	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RGS14—nephrolithiasis	0.00462	0.00739	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.00433	0.00693	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00428	0.00684	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00428	0.00684	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00421	0.00673	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00418	0.00669	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00415	0.00663	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.00393	0.00629	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—PTH—nephrolithiasis	0.00385	0.00615	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CHRM3—nephrolithiasis	0.00382	0.00611	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00381	0.0061	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.00374	0.00599	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00368	0.00589	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—PTH—nephrolithiasis	0.00349	0.00559	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00349	0.00558	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00349	0.00558	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.00342	0.00548	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00334	0.00535	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00318	0.00509	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00312	0.00499	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—DGKH—nephrolithiasis	0.00312	0.00499	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.00293	0.00468	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00291	0.00466	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.00273	0.00437	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.00266	0.00425	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00264	0.00423	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00264	0.00423	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00249	0.00398	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00246	0.00393	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00246	0.00393	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.00232	0.00372	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00232	0.00372	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00226	0.00362	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CHRM3—nephrolithiasis	0.00226	0.00361	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00219	0.0035	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00219	0.0035	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00212	0.00339	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTH—nephrolithiasis	0.00206	0.0033	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00198	0.00316	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.00193	0.0031	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.00192	0.00307	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0018	0.00288	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	0.00176	0.00281	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00175	0.0028	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00165	0.00263	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00163	0.00261	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00157	0.00251	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	0.00157	0.00251	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.00152	0.00243	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00149	0.00239	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.00135	0.00217	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.00133	0.00214	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00133	0.00214	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APRT—nephrolithiasis	0.00115	0.00184	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.00115	0.00184	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	0.00113	0.00182	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTH—nephrolithiasis	0.00104	0.00166	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SPP1—nephrolithiasis	0.00104	0.00166	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000965	0.00154	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000935	0.0015	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000883	0.00141	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000834	0.00133	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—AQP1—nephrolithiasis	0.00082	0.00131	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000741	0.00119	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000709	0.00113	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000709	0.00113	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	0.000521	0.000834	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000505	0.000808	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000457	0.000731	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000443	0.000709	CbGpPWpGaD
